Acasti Pharma News

Acasti Pharma | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer D'Andrea Carrie

May 11 04:14

Acasti Pharma | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer Kumar Amresh

May 11 04:10

Acasti Pharma | 4: Statement of changes in beneficial ownership of securities-Officer D'Andrea Carrie

May 9 07:24

Acasti Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Kumar Amresh

May 9 07:19

Acasti Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Macdonald R. Loch

May 9 07:19

Acasti Pharma | 4: Statement of changes in beneficial ownership of securities-Officer DelAversano Robert J

May 9 07:19

Acasti Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Kohli Prashant

May 9 07:19

Acasti Pharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-AIGH Capital Management, LLC(6.0%),Orin H(6.0%)

Apr 9 20:49

Acasti Pharma | 8-K: Current report

Apr 1 20:05

Acasti Pharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-BANK OF AMERICA CORPORATION(5.3%)

Feb 14 08:06

Acasti Pharma | 8-K: Acasti Announces Third Fiscal Quarter 2024 Financial Results and Business Highlights

Feb 12 21:04

Acasti Pharma | 10-Q: Quarterly report

Feb 12 20:34

Acasti Pharma | 3: Initial statement of beneficial ownership of securities-Officer DelAversano Robert J

Jan 8 13:00

Acasti Pharma | 8-K: Current report

Jan 8 13:00

Acasti Pharma | 4: Statement of changes in beneficial ownership of securities-Director Kavuru Vimal

Dec 21, 2023 05:08

Acasti Pharma | 4: Statement of changes in beneficial ownership of securities-Director Kottayil George

Dec 21, 2023 05:08

Acasti Pharma | 4: Statement of changes in beneficial ownership of securities-Director NEUGEBOREN EDWARD

Dec 21, 2023 05:06

Acasti Pharma | 4: Statement of changes in beneficial ownership of securities-Director DAVIS A BRIAN

Dec 21, 2023 05:06

Acasti Pharma | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Kohli Prashant

Dec 21, 2023 05:05

Acasti Pharma | 8-K: Current report

Dec 15, 2023 20:30